Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Elizaveta Efuni"'
Autor:
Pankti Reid, Sabina Sandigursky, Juhee Song, Maria A. Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S. Weber, Osama E. Rahma, Maria E. Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTPatients with preexisting autoimmune disease (pAID) are generally excluded from clinical trials for immune checkpoint inhibitors (ICIs) for cancer due to concern of flaring pAID. In this multi-center, retrospective observational study, we com
Externí odkaz:
https://doaj.org/article/e9e4bf95dfc442469304d1d2730ac304
Autor:
Jeffrey Weber, Michelle Krogsgaard, Anna Pavlick, Mehmet Altan, Sabina Sandigursky, Safa Houssein, Xerxes Pundole, Elizaveta Efuni, Samuel Cytryn
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4c4ed81616f04f1080b8fe2b0ecd46db
Autor:
Jeffrey S. Weber, Samuel Cytryn, Timothy B. Niewold, Anna C. Pavlick, Patrick Boland, Sabina Sandigursky, Elizaveta Efuni
Publikováno v:
J Clin Rheumatol
Introduction Immune checkpoint inhibitors (ICIs) are increasingly used to treat advanced cancer. Rheumatoid arthritis (RA) is associated with an increased risk of malignancies; however, patients with RA have been excluded from ICI trials. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2abfcfcdd02bc541219edd4dd1aa910
https://doi.org/10.1097/rhu.0000000000001314
https://doi.org/10.1097/rhu.0000000000001314
Autor:
Anna C. Pavlick, Maria E. Suarez-Almazor, Samuel Cytryn, Safa Houssein, Maryam Buni, Sabina Sandigursky, Chantal Saberian, Michelle Krogsgaard, Mehmet Altan, Adi Diab, Jeffrey S. Weber, Xerxes Pundole, Elizaveta Efuni, Noha Abdel-Wahab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Autoimmunity is associated with increased risk of malignancy. However, patients with pre-existing autoimmune diseases (AIDs) were excluded from immune checkpoint inhibitor (ICI) trials as these agents can cause immune-related adverse event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c71192f80c68530aa0ffb2bab0b96c1
https://doi.org/10.1136/jitc-2020-sitc2020.0658
https://doi.org/10.1136/jitc-2020-sitc2020.0658
Autor:
Elizaveta Efuni, Noah Cohen, Lina Jandorf, Felicia Reid, Elizabeth Schofield, Katherine N. DuHamel, Cristina Villagra
Publikováno v:
Health Behavior and Policy Review. 5:23-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79d6a2a9f8001864ae0bb1b3d9db3f8d
https://doi.org/10.14485/hbpr.5.2.3
https://doi.org/10.14485/hbpr.5.2.3
Publikováno v:
Psycho-Oncology. 24:1138-1144
Objectives Colorectal cancer (CRC) screening continues to be underused, particularly by Latinos. CRC and colonoscopy fear, worry, and fatalism have been identified as screening barriers in Latinos. The study purpose was to examine the relationship of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe9d99297eead1aee2521e039652ccf2
https://doi.org/10.1002/pon.3733
https://doi.org/10.1002/pon.3733
Autor:
Elizaveta Efuni, Lina Jandorf, Steven H. Itzkowitz, Rachel C. Shelton, Hayley S. Thompson, Errol J. Philip
Publikováno v:
Cancer Causes & Control. 25:1227-1231
The association between excess body weight and colorectal cancer screening is not well established. The purpose of this analysis was to explore, in the context of patients receiving navigation, whether obesity influences receipt of screening colonosc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e25b0fddbf0966b51b58c395a89260cf
https://doi.org/10.1007/s10552-014-0415-1
https://doi.org/10.1007/s10552-014-0415-1
Publikováno v:
Journal of Clinical Oncology. 37:e14176-e14176
e14176 Background: Autoimmunity is associated with increased risk of malignancy. However, patients with pre-existing autoimmune diseases (AIDs) have been excluded from trials of immune checkpoint inhibitors (ICIs) known to cause immune activation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ceb43f3e3b16041b925cecb28477db
https://doi.org/10.1200/jco.2019.37.15_suppl.e14176
https://doi.org/10.1200/jco.2019.37.15_suppl.e14176
Publikováno v:
Journal of Cancer Education. 28:582-590
Colorectal cancer (CRC) can be effectively prevented via screening colonoscopy, yet adherence rates remain low among Latinos. Interventions targeting individual and cultural barriers to screening are needed. We developed an educational brochure to ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a825750fbb44d637c44aeb3c7093d408
https://doi.org/10.1007/s13187-013-0506-9
https://doi.org/10.1007/s13187-013-0506-9
Autor:
Elizaveta Efuni, Katherine N. DuHamel, Tatiana D. Starr, Cristina Villagra, Gary Winkel, Lina Jandorf
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 23:B76-B76
Purpose: Colorectal cancer (CRC) can be prevented and treated effectively when detected early, especially via colonoscopy. However, only 39% of CRC cases in the United States are detected early. CRC screening continues to be underutilized particularl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18a1b99b5e367fd1dfc5b67ebbed227d
https://doi.org/10.1158/1538-7755.disp13-b76
https://doi.org/10.1158/1538-7755.disp13-b76